1
Postma, Maarten J.
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
2
3
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013